• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Maxim Group LLC to Host the Healthcare IT Virtual Conference on Wednesday, January 25th at 8:15 A.M. ET

    1/24/23 11:00:00 AM ET
    $AHI
    $CCEL
    $HSCS
    $ISPC
    Package Goods/Cosmetics
    Consumer Discretionary
    Misc Health and Biotechnology Services
    Health Care
    Get the next $AHI alert in real time by email

    NEW YORK, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Maxim Group LLC, a full-service investment banking, securities and wealth management firm, and M-Vest, a digital community built for issuers, investors, and thought leaders, present the Healthcare IT Virtual Conference. The conference will take place on Wednesday, January 25th at 8:15 A.M. ET

    Maxim Group LLC presents the Healthcare IT Virtual Conference. Participating companies focus on technology addressing rising health care costs, and scarcity of workers and resources. Learn about companies that are using technology and AI in the effort to improve healthcare outcomes and shift to value-based care. We also highlight companies that seek to provide low-cost, remote solutions and timely monitoring of patient risk factors.

    Click Here to Reserve your seat 

    Panel Topics 

    8:30 a.m. ET – iSpecimen (NASDAQ:ISPC)

    9:00 a.m. ET – Marpai (NASDAQ:MRAI)

    9:30 a.m. ET – Reliq Health Care (OTC:RQHTF)

    10:00 a.m. ET – OnTrak (NASDAQ:OTRK)

    10:30 a.m. ET – Cloud DX (OTC:CDXFF)

    11:00 a.m. ET – HeartSciences (NASDAQ:HSCS)

    11:30 a.m. ET – WELL Health Technologies (OTC:WHTCF)

    12:00 p.m. ET – Research Solutions (NASDAQ:RSSS)

    12:30 p.m. ET – Technology for Physicians Panel Discussion

    1:15 p.m. ET – Remote Heart Monitoring Panel Discussion

    2:00 p.m. ET – Digital Delivery of HC Products & Research Management Panel Discussion

    2:45 p.m. ET – Improve Patient Outcomes & Experiences Panel Discussion

    3:30 p.m. ET – Cryo-Cell International (NYSE:CCEL)

    4:00 p.m. ET – Respiri (ASX:RSH)

    4:30 p.m. ET – Advanced Health Intelligence (NASDAQ:AHI)

    About Maxim Group LLC 

    Maxim Group LLC is a full-service investment banking, securities and wealth management firm headquartered in New York. The Firm provides a full array of financial services including investment banking; private wealth management; and global institutional equity, fixed-income and derivatives sales & trading, equity research and prime brokerage services. Maxim Group is a registered broker-dealer with the U.S. Securities and Exchange Commission (SEC) and the Municipal Securities Rulemaking Board (MSRB) and is a member of FINRA SIPC, and NASDAQ. To learn more about Maxim Group, visit maximgrp.com 

      

    About M-Vest 

    M-Vest is a division of Maxim Group that services an online community and provides investors access to emerging growth companies through conferences, corporate presentations, and one-on-one meeting coordination. Its website, M-Vest.com, serves as a digital marketplace of ideas, founded to be community of issuers, investors, and thought leaders. This unique platform also provides access to investment opportunities through Regulation D and Regulation A securities offerings. To learn more, visit M-Vest.com 



    Contact
    Michael Quintavalla
    Chief Administrative Officer of Investment Banking
    212-895-3500

    Primary Logo

    Get the next $AHI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AHI
    $CCEL
    $HSCS
    $ISPC

    CompanyDatePrice TargetRatingAnalyst
    Advanced Health Intelligence Ltd.
    $AHI
    5/30/2024Buy → Hold
    Maxim Group
    Ontrak Inc.
    $OTRK
    12/5/2023$4.00Buy
    ROTH MKM
    Ontrak Inc.
    $OTRK
    3/9/2022$13.00 → $2.50Hold
    Canaccord Genuity
    Ontrak Inc.
    $OTRK
    3/9/2022$11.00 → $2.00Sector Perform
    RBC Capital
    Advanced Health Intelligence Ltd.
    $AHI
    1/18/2022$11.00Buy
    Maxim Group
    iSpecimen Inc.
    $ISPC
    1/4/2022$20.00Buy
    Craig-Hallum
    iSpecimen Inc.
    $ISPC
    11/22/2021$10.00 → $12.00Buy
    EF Hutton
    Ontrak Inc.
    $OTRK
    8/20/2021$35.00 → $9.00Market Perform → Underperform
    Cowen & Co.
    More analyst ratings

    $AHI
    $CCEL
    $HSCS
    $ISPC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Research Solutions to Participate in the 38th Annual ROTH Conference

    HENDERSON, Nev., March 19, 2026 (GLOBE NEWSWIRE) -- via IBN -- Research Solutions (NASDAQ:RSSS) today announces that members of its executive management team will be available for 1-on-1 and small group investor meetings at the 38th Annual ROTH Conference.  Event 38th Annual ROTH Conference  DateMarch 22-24, 2026  Format1-on-1 and Small Group Investor Meetings  LocationDana Point, CA         To schedule a meeting with Research Solutions management, please contact your ROTH representative. The company will be offering early previews of its new agentic research toolkit at the conference — attendees are encouraged to book time to learn more. This year's event will consist of 1-on-1 / small g

    3/19/26 9:35:00 AM ET
    $RSSS
    EDP Services
    Technology

    HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update

    Southlake, Texas, March 16, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc.  (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing electrocardiography ("ECG" or "EKG") through the integration of artificial intelligence ("AI"), today reported financial results for its fiscal third quarter ended January 31, 2026 ("FQ3 2026") and provided a business update. Third Quarter and Recent Highlights During the third quarter and subsequent period, the Company continued advancing the commercialization of its MyoVista Insights™ healthcare IT platform and submitted its MyoVista® wavECG™ device to the U.S. Food and Drug Administra

    3/16/26 4:15:00 PM ET
    $HSCS
    Industrial Specialties
    Health Care

    iSpecimen Achieves Rapid Procurement Milestone for Influenza Research

    Woburn, Massachusetts--(Newsfile Corp. - March 16, 2026) - iSpecimen Inc. (NASDAQ:ISPC) (the "Company"), a leading provider of human biospecimens for research, is proud to announce recent milestones that demonstrate the responsiveness and capabilities of its site network. Over the past several months, iSpecimen has been actively supporting customer research by sourcing high-quality respiratory samples, with a particular focus on influenza. Most recently, iSpecimen successfully collected approximately 500 influenza swab samples over a period of several weeks to support a customer research project—demonstrating its ability to respond quickly to time-sensitive research needs. The rapid turnarou

    3/16/26 7:47:00 AM ET
    $ISPC
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $AHI
    $CCEL
    $HSCS
    $ISPC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Wells David R.

    4 - HeartSciences Inc. (0001468492) (Issuer)

    1/12/26 8:03:32 PM ET
    $HSCS
    Industrial Specialties
    Health Care

    SEC Form 4 filed by Director Bent Bruce

    4 - HeartSciences Inc. (0001468492) (Issuer)

    1/12/26 8:03:15 PM ET
    $HSCS
    Industrial Specialties
    Health Care

    SEC Form 4 filed by Chairman, Co-CEO Portnoy David

    4 - CRYO CELL INTERNATIONAL INC (0000862692) (Issuer)

    1/9/26 5:00:15 PM ET
    $CCEL
    Misc Health and Biotechnology Services
    Health Care

    $AHI
    $CCEL
    $HSCS
    $ISPC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Advanced Health Intelligence downgraded by Maxim Group

    Maxim Group downgraded Advanced Health Intelligence from Buy to Hold

    5/30/24 8:24:49 AM ET
    $AHI
    Package Goods/Cosmetics
    Consumer Discretionary

    ROTH MKM initiated coverage on Ontrak with a new price target

    ROTH MKM initiated coverage of Ontrak with a rating of Buy and set a new price target of $4.00

    12/5/23 8:03:01 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Canaccord Genuity reiterated coverage on Ontrak with a new price target

    Canaccord Genuity reiterated coverage of Ontrak with a rating of Hold and set a new price target of $2.50 from $13.00 previously

    3/9/22 9:09:19 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    $AHI
    $CCEL
    $HSCS
    $ISPC
    Financials

    Live finance-specific insights

    View All

    Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2025

    Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the "Company"), the world's first private cord blood bank to separate and store stem cells in 1992, announced results for its fiscal year ended November 30, 2025. Financial Results Revenue Consolidated revenues for fiscal 2025 were $31.6 million compared to $32.0 million for fiscal 2024. The revenues for fiscal 2025 consisted of $31.4 million in processing and storage fee revenue, $54,000 in product revenue and $130,000 in public banking revenue compared to $31.6 million in processing and storage fee revenue, $68,000 in product revenue and $367,000 in public banking revenue for fiscal 2024. Net (Loss) Income The Company repo

    2/27/26 5:00:00 PM ET
    $CCEL
    Misc Health and Biotechnology Services
    Health Care

    Research Solutions Reports Second Quarter Fiscal Year 2026 Results

    Reports 14% Increase in ARR to $21.8 Million, Net Income of $547,000 and 36% Year-over-Year Growth in Adjusted EBITDA HENDERSON, Nev., Feb. 12, 2026 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ:RSSS), the leading AI-powered research workflow platform, reported financial results for its fiscal second quarter ended December 31, 2025. Fiscal Second Quarter 2026 Summary (compared to prior-year quarter) Annual Recurring Revenue ("ARR") up 14% to $21.8 million, which includes approximately $15.3 million of B2B ARR and $6.4 million of B2C ARR.Forty-seven net new deployments in th

    2/12/26 4:05:00 PM ET
    $RSSS
    EDP Services
    Technology

    Research Solutions to Announce Second Quarter Fiscal Year 2026 Results on Thursday, February 12, 2026

    HENDERSON, Nev., Jan. 29, 2026 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ:RSSS), the leading AI-powered research workflow platform, will hold a conference call to discuss its financial results for the second quarter fiscal 2026 ended December 31, 2025, on Thursday, February 12, 2026, at 5:00 p.m. ET. A press release containing the Company's financial results will be issued following the market close. Management will host the conference call, followed by a question-and-answer period. Date: Thursday, February 12, 2026Time: 5:00 p.m. ET (2:00 p.m. PT)Dial-in number: 1-203-5

    1/29/26 2:50:00 PM ET
    $RSSS
    EDP Services
    Technology

    $AHI
    $CCEL
    $HSCS
    $ISPC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Eitan Yaron bought $100,000 worth of shares (100,000 units at $1.00), increasing direct ownership by 10% to 1,089,073 units (SEC Form 4)

    4 - Marpai, Inc. (0001844392) (Issuer)

    11/12/25 6:50:17 AM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    Director Shiv Sagiv bought $50,000 worth of shares (50,000 units at $1.00), increasing direct ownership by 23% to 272,000 units (SEC Form 4)

    4 - Marpai, Inc. (0001844392) (Issuer)

    11/12/25 6:49:18 AM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    Director Pons Robert M bought $50,000 worth of shares (50,000 units at $1.00), increasing direct ownership by 16% to 359,200 units (SEC Form 4)

    4 - Marpai, Inc. (0001844392) (Issuer)

    11/12/25 6:47:30 AM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    $AHI
    $CCEL
    $HSCS
    $ISPC
    SEC Filings

    View All

    SEC Form DEFA14A filed by HeartSciences Inc.

    DEFA14A - HeartSciences Inc. (0001468492) (Filer)

    3/19/26 5:00:56 PM ET
    $HSCS
    Industrial Specialties
    Health Care

    SEC Form DEF 14A filed by HeartSciences Inc.

    DEF 14A - HeartSciences Inc. (0001468492) (Filer)

    3/17/26 4:16:35 PM ET
    $HSCS
    Industrial Specialties
    Health Care

    HeartSciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - HeartSciences Inc. (0001468492) (Filer)

    3/16/26 4:15:52 PM ET
    $HSCS
    Industrial Specialties
    Health Care

    $AHI
    $CCEL
    $HSCS
    $ISPC
    Leadership Updates

    Live Leadership Updates

    View All

    MARPAI, INC. HIRES PHARMACY EXECUTIVE MIMI DAVIS AS PRESIDENT OF MARPAIRX TO DRIVE STRATEGIC GROWTH

    TAMPA, Fla., Jan. 27, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Pharmacy Benefit Management (PBM) and Third-Party Administration (TPA) services, announced the hiring of Mimi Davis as President of MarpaiRx. Davis, a distinguished leader in the pharmacy services sector, will oversee the strategic expansion and operational scaling of Marpai's pharmacy benefit offerings. Davis joins Marpai from Knipper Health, where she served as Executive Vice President of Operations. Her deep industry roots include a significant tenure at Eagle Pharmacy—a former HillCour portfolio company—which was acquired by Knipper in 2020. With

    1/27/26 8:23:00 AM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    MARPAI HIRES DALLAS SCRIP AS CHIEF OPERATING OFFICER

    Marpai Bolsters Leadership Team to Drive Profitable High-Growth Strategy with Key Executive Appointment  TAMPA, Fla., May 13, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology and Third-Party Administration (TPA) services, today announced a significant addition to its leadership team with the appointment of Dallas Scrip as Chief Operating Officer (COO) and President of MarpaiRx. This strategic hire underscores Marpai's commitment to accelerating profitable growth and enhancing operational excellence within the dynamic healthcare landscape. Prior to joining Marpai, Mr. Scrip demonstrated significant success in startup, ear

    5/13/25 9:01:00 AM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board

    Southlake, TX, May 07, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced the appointment of Dr. Girish Nadkarni, MD, Dr. Joshua Lampert, MD, and Dr. Akhil Vaid, MBBS, to its Scientific Advisory Board. These appointments underscore HeartSciences' commitment to advancing and transforming data-driven AI-ECG technology. "We are honored to welcome Dr. Girish Nadkarni, Dr. Joshua Lampert, and Dr. Akhil Vaid to our Scientific Advisory Board," said Andrew Simpson, CEO of HeartScien

    5/7/25 9:00:00 AM ET
    $HSCS
    Industrial Specialties
    Health Care

    $AHI
    $CCEL
    $HSCS
    $ISPC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Research Solutions Inc

    SC 13D/A - Research Solutions, Inc. (0001386301) (Subject)

    12/9/24 5:34:36 PM ET
    $RSSS
    EDP Services
    Technology

    Amendment: SEC Form SC 13D/A filed by Marpai Inc.

    SC 13D/A - Marpai, Inc. (0001844392) (Subject)

    12/9/24 5:14:07 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SC 13D/A filed by Research Solutions Inc

    SC 13D/A - Research Solutions, Inc. (0001386301) (Subject)

    12/5/24 3:54:23 PM ET
    $RSSS
    EDP Services
    Technology